Adipocytokines, Hepatic and Inflammatory Biomarkers and Incidence of Type 2 Diabetes. The CoLaus Study

• Pedro Marques-Vidal ,

  * E-mail: Pedro-Manuel.Marques-Vidal@chuv.ch

  Affiliation Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland

  ⨯
• Rémy Schmid,

  Affiliation Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland

  ⨯
• Murielle Bochud,

  Affiliation Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland

  ⨯
• François Bastardot,

  Affiliation Department of Medicine, Internal Medicine, CHUV and Faculty of Biology and Medicine, Lausanne, Switzerland

  ⨯
• Roland von Känel,

  Affiliation Division of Psychosomatic Medicine, Bern University Hospital, Inselspital, and University of Bern, Bern, Switzerland

  ⨯
• Fred Paccaud,

  Affiliation Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland

  ⨯
• Jennifer Glaus,

  Affiliation Department of Psychiatry, CHUV, Lausanne, Switzerland

  ⨯
• Martin Preisig,

  Affiliation Department of Psychiatry, CHUV, Lausanne, Switzerland

  ⨯
• Gérard Waeber,

  Affiliation Department of Medicine, Internal Medicine, CHUV and Faculty of Biology and Medicine, Lausanne, Switzerland

  ⨯
• Peter Vollenweider

  Affiliation Department of Medicine, Internal Medicine, CHUV and Faculty of Biology and Medicine, Lausanne, Switzerland

  ⨯